AbbVie's (NYSE:ABBV) autoimmune disease biologic Humira (adalimumab) and Pfizer (NYSE:PFE)/BioNTech's (BNTX) COVID-19 shot ...

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...

In October 2019, Janet Woodcock, then the director of the US Food and Drug Administration’s Center for Drug Evaluation and ...

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Nearly 28 million people in the U.S. have asthma, or about one in 12 people — and depending on where you live, the condition ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

An asthma attack is much more than just feeling winded after exercise and needing to catch your breath. Learn what can ...

GREEN BAY, Wis. (WBAY) - Maybe your allergies or asthma are really bad right now. Experts call the third week in September “Asthma Peak Week.” More than 25 million people in the U.S. live with asthma.

The study of children in Madison and six other cities found higher rates of asthma among children who live in areas graded low for home loans in the 1930s.

Nagpur: Experts have warned that frequent coughing could be a sign of underlying respiratory issues, particularly asthma.

We West Virginians need to lose some weight. That is not polite to say, and not something most of us want to hear, but the numbers bear this out. The recently released Adult Obesity Prevalence Maps fo ...